The patient transit assistance scheme: a consumer's perspective.

Area of Science:

• Health Services Research
• Patient Support Programs
• Oncology Patient Travel Assistance

Background:

• Patients with haematological malignancies often require travel for specialist cancer treatment.
• Relocation for treatment incurs significant financial and emotional hardship for patients and families.
• Existing patient assistance schemes may not be fully utilized or known.

Purpose of the Study:

• To evaluate patient experiences with the Patient Transit Assistance Scheme (PTAS) in Queensland.
• To identify the importance and accessibility challenges of the PTAS for patients undergoing treatment for haematological malignancies.
• To understand the impact of relocation for specialist treatment on patients.

Main Methods:

• State-wide research conducted in Queensland.
• Data collected from the perspective of patients with haematological malignancy.
• Qualitative or quantitative analysis of patient travel experiences and scheme utilization.

Main Results:

• The PTAS is critically important for patients and families, helping to mitigate financial difficulties.
• There is a notable lack of community awareness regarding the PTAS.
• Insufficient access to the scheme by those who could benefit, confirming prior research on relocation hardships.

Conclusions:

• The PTAS provides essential support for cancer patients requiring travel for treatment.
• Increased community awareness and improved accessibility of the PTAS are necessary.
• Addressing financial and emotional hardships associated with treatment relocation remains a key concern.